SCHEMBL24762020

SCHEMBL24762020

CCCN(C1CCN(C(=O)C(F)(F)F)CC1)S(=O)(=O)c1ccc(S(=O)(=O)Nc2ccc(Cl)c3c(Cl)c[nH]c23)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.35
▸ PKM P14618 1/20 0.35
▸ LMNA P02545 3/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ CACNA1B Q00975 3/20 0.34
▸ CACNA1C Q13936 1/20 0.34
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA3 P07451 1/20 0.33
▸ CA6 P23280 1/20 0.33
▸ CA5A P35218 1/20 0.33
▸ CA7 P43166 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ CRBN Q96SW2 1/20 0.33
▸ CA14 Q9ULX7 1/20 0.33
▸ CA5B Q9Y2D0 1/20 0.33
▸ HTT P42858 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ NR1I2 O75469 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24762624 0.85 CA1 (0.32) ALDH1A1LMNACA12CA1CA2
SCHEMBL24762023 0.84 SLC6A2 (0.42) ALDH1A1PKMLMNANPSR1CA12
SCHEMBL24762038 0.82 CA1 (0.37) LMNACA12CA1CA2CA3
SCHEMBL24762176 0.82 PDK1 (0.40) CA12CA1CA2CA3CA6
SCHEMBL24762659 0.81 CA1 (0.33) ALDH1A1LMNACA12CA1CA2
SCHEMBL24762672 0.81 CA1 (0.33) ALDH1A1LMNACA12CA1CA2
SCHEMBL24762010 0.79 CA1 (0.39) ALDH1A1PKMLMNANPSR1CA12
SCHEMBL24762667 0.78 CA1 (0.34) ALDH1A1PKMLMNACA12CA1
SCHEMBL27238549 0.77 CACNA1B (0.43) ALDH1A1PKMLMNANPSR1CACNA1B
SCHEMBL24761960 0.76 ALDH1A1 (0.48) ALDH1A1PKMLMNANPSR1CACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240190821-A1 SULFONAMIDE SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF TRIANA BIOMEDICINES INC (US) 2024-06-13 — — US disclosed
WO-2022169755-A1 SULFONAMIDE SUBSTITUTED N-(1H-INDOL-7-YL) BENZENESULFONAMIDES AND USES THEREOF TRIANA BIOMEDICINES, INC. (US) 2022-08-11 — — WO disclosed
WO-2022169755-A1 SULFONAMIDE SUBSTITUTED N-(1H-INDOL-7-YL) BENZENESULFONAMIDES AND USES THEREOF TRIANA BIOMEDICINES, INC. (US) 2022-08-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240190821-A1 SULFONAMIDE SUBSTITUTED N-(1H-INDOL-7-YL)BENZENESULFONAMIDES AND USES THEREOF PACSIN2, TPX2, PRSS12 ALDH1A1 3608/4885PKM 4012/4885LMNA 2712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback